Related Experiment Video
Updated: Aug 9, 2026
09:40
An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
Published on: April 17, 2020
[Neoadjuvant therapy in oesophageal cancer surgery]
1Klinikum Heidenheim, Abt. für Viszeral-, Thorax- und Gefässchirurgie. Andreas.Imdahl@Kliniken-Heidenheim.de
Zentralblatt Fur Chirurgie
|April 14, 2006
Summary
Neoadjuvant therapy, including preoperative radio-chemotherapy, offers a survival advantage for some esophageal cancer patients. However, its widespread use is limited by conflicting data and a lack of predictive response markers.
Area of Science:
- Oncology
- Surgical Oncology
- Gastroenterology
Context:
- Esophageal cancer treatment often involves neoadjuvant therapy to improve patient outcomes.
- Surgical resection is the primary treatment for nonmetastatic disease.
- Adjuvant therapy post-resection is generally not recommended.
Purpose:
- To evaluate the efficacy and indications of neoadjuvant therapy in esophageal cancer.
- To review the benefits of preoperative radiotherapy, chemotherapy, and combined radio-chemotherapy.
- To identify challenges and future directions in neoadjuvant treatment strategies.
Summary:
- Preoperative radiotherapy shows minimal benefit for esophageal cancer and is not recommended.
- Data on preoperative chemotherapy efficacy are conflicting.
- Preoperative combined radio-chemotherapy yields a complete tumor response in 20-25% of patients, offering a survival advantage, but lacks predictive markers for treatment response.
Impact:
- Meta-analyses suggest a small overall benefit for perioperative radio-chemotherapy.
- Lack of predictive markers and conflicting data hinder broad consensus on neoadjuvant therapy indications.
- Further research is needed to optimize patient selection and treatment protocols for neoadjuvant therapy in esophageal cancer.
Related Concept Videos
01:21Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:26Esophageal Strictures-II: Clinical Features and Management
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
01:24Esophageal Varices-I: Introduction
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
01:27Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
01:28Esophageal Perforation-II: Clinical Manifestations and Management
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations: